M&T Bank Corp Dynavax Technologies Corp Transaction History

M&T Bank Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$3.46 - $6.93 $59,972 - $120,117	-17,333 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.69 - $4.85 $9,813 - $17,692	3,648 Added 26.66%	17,333 $62,000
Q2 2019 Aug 12, 2019	BUY	$3.65 - $7.89 $11,373 - $24,585	3,116 Added 29.48%	13,685 $54,000
Q1 2019 May 15, 2019	BUY	$7.08 - $12.09 $74,828 - $127,779	10,569 New	10,569 $78,000

288

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.74B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.